- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06128746
rTMS-behandling av spasticitet hos barn med cerebral pares - en RCT
Repetitiv transkraniell magnetisk stimulering (rTMS) för behandling av spasticitet hos barn med hemiplegisk cerebral pares - en randomiserad kontrollerad studie
This RCT aims to investigate the effect of repetitive transcranial magnatic stimulation (rTMS) in treating children with hemiplegoc cerebral palsy. The study will measure any improvement in spasticity after using contra-lesional inhibitory rTMS follow by intensive limb training.
Participants will attend a 10-day rTMS treatment sessions, follow by intensive training of the impaired limb. They will also undergo MRI scans before and after the treatment to investiagte the underlying neurophysiological mechanisms that lead to changes clinically by using TMS as well as MR-DKI. Researchers will compare the intervention group and the sham group to see if rTMS could result in improvement of participants' spasticity.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Cerebral palsy is the most common cause of lifelong physical disability in childhood, with an estimated prevalence of 1.5 per 1000 living biths for primary school-aged children. Spasticity is the most common symptoms in children with cerebral palsy, leading to muscle weakness affecting gross motor functions and causing complications such as pain, contracture and subluzation which will lead to inability to perform activity-based training and subsequently lead to further muscle weakness. Standard therapy with regular physiotherapy and occupational therapy are essential but time-consuming and the effects might not last for longer duration. Patients or caregivers decline medications because of side effects drowsiness while other interventions such as intra-thecal baclofen pump, rhizotomy or surgery are invasive.
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has the ability to modulate excitation of the motor cortex area of the brain. There were past studies suggesting that using contralesional inhibitory rTMS was safe and feasible for patients with paediatric subcortical stroke and seemed to improve hand function in patients with hemiparesis. However, limited studies have been published on the effects of rTMS on improving spasticity in children with cerebral palsy. Hence, the objective of this study is to use low-frequency rTMS to the contra-lesional hemisphere in children with hemiplegic cerebral palsy to investigate if rTMS follow by intensive limb training would improve spasiticity of these children and whether the improvement can be sustained for a longer time. The underlying mechanisms that lead to the changes clinically will also be investigated by TMS and MRI.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Winnie Wan Yee Tso, MBBS
- Telefonnummer: +85222554295
- E-post: wytso@hku.hk
Studera Kontakt Backup
- Namn: Chai Yin Charlie Fan, MPhil, OTR
- Telefonnummer: +85222554375
- E-post: charliefan@connect.hku.hk
Studieorter
-
-
Hong Kong
-
Hong Kong, Hong Kong, Hong Kong, 0000
- Rekrytering
- Li Ka Shing Faculty of Medicine
-
Kontakt:
- Charlie Fan, MPhil, OTR
- Telefonnummer: +85222554375
- E-post: charliefan@connect.hku.hk
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients aged between 4 years and 18 years
- Diagnosis of hemiplegia
- Upper limb spasticity ≥ 1
- IQ ≥ 50
Exclusion Criteria:
- Any contra-indications to rTMS
- Severe spasticity (score of 4 or more in Ashworth scale)
- Uncontrollable epilepsy
- History of Botulinum toxin A injection in previous 6 months
- Upper limb casting in previous 6 months
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Interventional rTMS group
The intervention group will receive 1 Hz active rTMS during treatment, lasting for 20 minutes, follow up by 1.5 hours of motor training. |
1 Hz rTMS treatment for 20 mins, followed by 1.5 hours of motor training. |
|
Sham Comparator: Sham rTMS group
The sham group will not receive any Hz of rTMS during treatment, also lasting for 20 minutes with 1.5 hours of motor training. |
Sham Hz rTMS treatment for 20 mins, followed by 1.5 hours of motor training. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Modified Ashworth Scale
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
Clinical measure of spasticity. Scores range from 0 to 4, with a higher score indicate worse in muscle tone |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
|
The range of motion scores
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
ROM of thumb adduction, wrist dorsal flexion and extension, and elbow dorsal flexion and extension. Patients' range of motion score will be compared to the normative values |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
|
The Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2)
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
The BOT-2 provides a comprehensive overview of fine and gross motor skills in children and young adults within school age-range. |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Gross motor function measure
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
Changes in motor function. A 4-point Likert scale with higher score indicates better motor function |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
|
Pediatric Quality of Life Cerebral Palsy module
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
Quality of life measurement. Scores range from 0 to 100 with higher score indicate better quality of life. |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
|
MRI Brain: fMRI and DKI
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
Functional MRI and Diffusion Kurtosis Imaging measuring the brain microstructural changes and structural connectivity during the intervention |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
|
Purdue Pegboard Test
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention
|
A standardized evaluation tool used to measure gross movements of hands, fingers, and arms, as well as fine fingertip dexterity. |
Baseline, Day 10, 17 of intervention and 2 months post intervention
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Neurologiska manifestationer
- Muskuloskeletala sjukdomar
- Hjärnsjukdomar
- Sjukdomar i centrala nervsystemet
- Sjukdomar i nervsystemet
- Muskelsjukdomar
- Muskelhypertoni
- Neuromuskulära manifestationer
- Hjärnskada, kronisk
- Patologiska tillstånd, tecken och symtom
- Tecken och symtom
- Muskelspasticitet
- Cerebral pares
- Terapeutik
- Magnetfältterapi
- Transkraniell magnetisk stimulering
Andra studie-ID-nummer
- rTMSCPHKU
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .